Drug Insight: Gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy

Keyphrases

• Adverse Effects 100%
• In Cancer 100%
• Cancer Therapy 100%
• Adverse Events 100%
• Toxic Effects 100%
• Molecular Targeted Agents 100%
• Gastrointestinal 100%
• Recent Advances 50%
• Molecular Mechanism 50%
• Cancer Treatment 50%
• Monoclonal Antibody 50%
• Hepatotoxicity 50%
• Treatment Discontinuation 50%
• Diarrhea 50%
• Tyrosine 50%
• Cancer Mechanisms 50%
• Cancer Pathways 50%
• Tyrosine Kinase Inhibitor 50%
• Cancer Control 50%
• European Medicines Agency 50%
• Incidence Trends 50%
• Molecular Targeted Therapy 50%
• Clinical Pattern 50%
• Gastrointestinal Side Effects 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Adverse Event 100%
• Toxicity 40%
• Hepatotoxicity 20%
• Diarrhea 20%
• Protein Tyrosine Kinase Inhibitor 20%
• Monoclonal Antibody 20%